O. Oldenburg, B. Lamp, L. Faber, H. Teschler, D. Horstkotte et al., Sleep-disordered breathing in patients with symptomatic heart failure: a contemporary study of prevalence in and characteristics of 700 patients, Eur J Heart Fail, vol.9, pp.251-257, 2007.

W. Grimm, A. Sosnovskaya, N. Timmesfeld, O. Hildebrandt, and U. Koehler, Prognostic impact of central sleep apnea in patients with heart failure, J Card Fail, vol.21, pp.126-133, 2015.

S. Javaheri, R. Shukla, H. Zeigler, and L. Wexler, Central sleep apnea, right ventricular dysfunction, and low diastolic blood pressure are predictors of mortality in systolic heart failure, J Am Coll Cardiol, vol.49, pp.2028-2034, 2007.

T. Bitter, N. Westerheide, C. Prinz, M. S. Hossain, J. Vogt et al., Oldenburg O. Cheyne-Stokes respiration and obstructive sleep apnoea are independent risk factors for malignant ventricular arrhythmias requiring appropriate cardioverter-defibrillator therapies in patients with congestive heart failure, Eur Heart J, vol.32, pp.61-74, 2011.

T. D. Bradley, A. G. Logan, R. J. Kimoff, F. Series, D. Morrison et al., Continuous positive airway pressure for central sleep apnea and heart failure, N Engl J Med, vol.353, pp.2025-2033, 2005.

B. K. Sharma, J. P. Bakker, D. G. Mcsharry, A. S. Desai, S. Javaheri et al., Adaptive servoventilation for treatment of sleep-disordered breathing in heart failure: a systematic review and meta-analysis, Chest, vol.142, pp.1211-1221, 2012.

M. R. Cowie, H. Woehrle, K. Wegscheider, C. Angermann, M. P. Ortho et al., Adaptive servo-ventilation for central sleep apnea in systolic heart failure, N Engl J Med, vol.373, pp.1095-1105, 2015.

U. J. Magalang and A. I. Pack, Heart failure and sleep-disordered breathing-The plot thickens, N Engl J Med, vol.373, pp.1166-1167, 2015.

C. Eulenburg, K. Wegscheider, H. Woehrle, C. Angermann, M. P. Ortho et al., Mechanisms underlying increased mortality risk in patients with heart failure and reduced ejection fraction randomly assigned to adaptive servoventilation in the SERVE-HF study: results of a secondary multistate modelling analysis, Lancet Respir Med, vol.4, pp.873-881, 2016.

M. R. Cowie, H. Woehrle, K. Wegscheider, C. Angermann, M. P. Ortho et al., Rationale and design of the SERVE-HF study: treatment of sleep-disordered breathing with predominant central sleep apnoea with adaptive servo-ventilation in patients with chronic heart failure, Eur J Heart Fail, vol.15, pp.937-943, 2013.

M. Lundberg, A. Eriksson, B. Tran, E. Assarsson, and S. Fredriksson, Homogeneous antibody-based proximity extension assays provide sensitive and specific detection of low-abundant proteins in human blood, Nucleic Acids Res, vol.39, p.102, 2011.

S. Van-buuren and K. Groothuis-oudshoorn, mice: multivariate imputation by chained equations in R, J Stat Softw, vol.45, pp.1-67, 2011.

F. E. Harrell, K. L. Lee, and D. B. Mark, Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors, Stat Med, vol.15, pp.361-387, 1996.

P. Ponikowski, A. A. Voors, S. D. Anker, H. Bueno, J. G. Cleland et al., ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The task force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contribution of the Heart Failure Association (HFA) of the ESC, Eur J Heart Fail, vol.18, pp.891-975, 2016.

C. W. Yancy, M. Jessup, B. Bozkurt, J. Butler, C. De et al.,

, ACCF/AHA guideline for the management of heart failure: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines, Circulation, vol.128, pp.1810-1852, 2013.

R. C. Johnson, G. W. Nelson, J. L. Troyer, J. A. Lautenberger, B. D. Kessing et al., Accounting for multiple comparisons in a genome-wide association study (GWAS), BMC Genomics, vol.11, p.724, 2010.

L. Kang, W. Chen, N. A. Petrick, and B. D. Gallas, Comparing two correlated C indices with right-censored survival outcome: a oneshot nonparametric approach, Stat Med, vol.34, pp.685-703, 2015.

M. J. Pencina, D. Sr, D. Jr, and R. S. Vasan, Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond

, Stat Med, vol.27, pp.157-172, 2008.

H. Uno, L. Tian, T. Cai, I. S. Kohane, and L. J. Wei, A unified inference procedure for a class of measures to assess improvement in risk prediction systems with surviva data, Stat Med, vol.32, pp.2430-2442, 2013.

N. Ibrahim and J. L. Januzzi, The potential role of natriuretic peptides and other biomarkers in heart failure diagnosis, prognosis and management, Expert Rev Cardiovasc Ther, vol.13, pp.1017-1030, 2015.

A. A. Voors, W. Ouwerkerk, F. Zannad, D. J. Van-veldhuisen, N. J. Samani et al., Development and validation of multivariable models to predict mortality and hospitalization in patients with heart failure

, Eur J Heart Fail, vol.19, pp.627-634, 2017.

W. H. Yin, J. W. Chen, A. N. Feng, S. J. Lin, and S. Young, Multimarker approach to risk stratification among patients with advanced chronic heart failure, Clin Cardiol, vol.30, pp.397-402, 2007.

A. Bayes-genis, A. M. Richards, A. S. Maisel, C. Mueller, and B. Ky, Multimarker testing with ST2 in chronic heart failure, Am J Cardiol, vol.115, pp.76-80, 2015.

B. G. Demissei, G. Cotter, M. F. Prescott, G. M. Felker, G. Filippatos et al., A multimarker multi-time point-based risk stratification strategy in acute heart failure: results from the RELAX-AHF trial, Eur J Heart Fail, vol.19, pp.1001-1010, 2017.

R. Kakkar and R. T. Lee, The IL-33/ST2 pathway: therapeutic target and novel biomarker, Nat Rev Drug Discov, vol.7, pp.827-840, 2008.

D. A. Pascual-figal and J. L. Januzzi, The biology of ST2: the International ST2 Consensus Panel, Am J Cardiol, vol.115, pp.3-7, 2015.

M. Emdin, A. Aimo, G. Vergaro, A. Bayes-genis, J. Lupon et al., sST2 predicts outcome in chronic heart failure beyond NT-proBNP and high-sensitivity troponin T, J Am Coll Cardiol, vol.72, pp.2309-2320, 2018.

A. Aimo, G. Vergaro, C. Passino, A. Ripoli, B. Ky et al., Prognostic value of soluble suppression of tumorigenicity-2 in chronic heart failure: a meta-analysis, JACC Heart Fail, vol.5, pp.280-286, 2017.

K. Broch, T. Ueland, S. H. Nymo, J. Kjekshus, J. Hulthe et al., Soluble ST2 is associated with adverse outcome in patients with heart failure of ischaemic aetiology, Eur J Heart Fail, vol.14, pp.268-277, 2012.

I. S. Anand, T. S. Rector, M. Kuskowski, J. Snider, and J. N. Cohn, Prognostic value of soluble ST2 in the Valsartan Heart Failure Trial, Circ Heart Fail, vol.7, pp.418-426, 2014.

R. Ferrari and P. Rizzo, The Notch pathway: a novel target for myocardial remodelling therapy?, Eur Heart J, vol.35, pp.2140-2145, 2014.

H. Ragot, A. Monfort, M. Baudet, F. Azibani, L. Fazal et al., Loss of Notch3 signaling in vascular smooth muscle cells promotes severe heart failure upon hypertension, Hypertension, vol.68, pp.392-400, 2016.

E. Tzima, M. Irani-tehrani, W. B. Kiosses, E. Dejana, D. A. Schultz et al., A mechanosensory complex that mediates the endothelial cell response to fluid shear stress, Nature, vol.437, pp.426-431, 2005.

M. Dematteis, C. Julien, C. Guillermet, N. Sturm, S. Lantuejoul et al., Intermittent hypoxia induces early functional cardiovascular remodeling in mice, Am J Respir Crit Care Med, vol.177, pp.227-235, 2008.

K. C. Wollert, T. Kempf, and L. Wallentin, Growth differentiation factor 15 as a biomarker in cardiovascular disease, Clin Chem, vol.63, pp.140-151, 2017.

I. M. Seropian, S. Toldo, B. W. Van-tassell, and A. Abbate, Anti-inflammatory strategies for ventricular remodeling following ST-segment elevation acute myocardial infarction, J Am Coll Cardiol, vol.63, pp.1593-1603, 2014.

I. S. Anand, T. Kempf, T. S. Rector, H. Tapken, T. Allhoff et al., Serial measurement of growth-differentiation factor-15 in heart failure: relation to disease severity and prognosis in the Valsartan Heart Failure Trial, Circulation, vol.122, pp.1387-1395, 2010.

N. Bouabdallaoui, B. Claggett, M. R. Zile, J. Mcmurray, E. O'meara et al., Growth differentiation factor-15 is not modified by sacubitril/ valsartan and is an independent marker of risk in patients with heart failure and reduced ejection fraction: the PARADIGM-HF trial, Eur J Heart Fail, vol.20, pp.1701-1709, 2018.

K. C. Wollert and T. Kempf, Growth differentiation factor 15 in heart failure: an update, Curr Heart Fail Rep, vol.9, pp.337-345, 2012.

M. George, J. A. Srivatsan, V. Muthukumar, R. Dhandapani, and V. E. , GDF 15-a novel biomarker in the offing for heart failure, Curr Cardiol Rev, vol.12, pp.37-46, 2016.

J. Tromp, M. A. Khan, I. T. Klip, S. Meyer, R. A. De-boer et al., Biomarker profiles in heart failure patients with preserved and reduced ejection fraction, J Am Heart Assoc, vol.6, p.3989, 2017.

J. Tromp, B. D. Westenbrink, W. Ouwerkerk, D. J. Van-veldhuisen, N. J. Samani et al., Identifying pathophysiological mechanisms in heart failure with reduced versus preserved ejection fraction, J Am Coll Cardiol, vol.72, pp.1081-1090, 2018.

M. R. Cowie, H. Woehrle, K. Wegscheider, E. Vettorazzi, S. Lezius et al., Adaptive servo-ventilation for central sleep apnoea in systolic heart failure: results of the major substudy of SERVE-HF
URL : https://hal.archives-ouvertes.fr/hal-01741506

, Eur J Heart Fail, vol.20, pp.536-544, 2018.

, Biomarkers for risk prediction in HF with Central Sleep Apnoea